Skip to content
Search

Latest Stories

Submit Guest Post

Pfizer's Covid-19 vaccine gets approval in Sri Lanka

SRI LANKA is battling a third wave of coronavirus. To curb the number of cases the government has approved Pfizer’s COVID-19 vaccine.

It is the first South Asian country to approve Pfizer’s vaccine


‘The government would order 5 million doses of the Pfizer vaccine,’ said Dr. Sudharshani Fernandopulle, the minister overseeing the fight against the epidemic.

The island is trying to secure other vaccines as the Serum Institute of India has suspended the delivery of AstraZeneca's Covishield vaccine due to spiraling coronavirus infections in India.

This week, it has also approved Russia's Sputnik and China's Sinopharm vaccines for emergency use.

Thursday (6) Sri Lanka received the first batch of 15,000 doses of the Sputnik V. The island had ordered 13 million Sputnik V doses.

Due to the grave COVID situation in India, Sri Lanka’s next order is getting delayed posing problems for the second dose.

The nation reported 1,914 new cases and 19 deaths in the past 24 hours, according to federal health data, and its total number of active cases is higher than any point since the pandemic began.

Infections surged after crowded celebrations for traditional New Year last month.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cervical -cancer-hpv-vaccine

HPV is the most common sexually transmitted infection

Photo for representation: iStock

HPV vaccine reduces cervical cancer deaths to near zero, study finds

Highlights

  • No women aged 20–24 died from cervical cancer in England between 2020 and 2024
  • HPV vaccination is estimated to have prevented nearly 200 deaths among young women
  • Study provides first direct evidence linking HPV vaccination to reduced cervical cancer mortality
  • Vaccine introduced for girls in 2008 in the UK
  • Researchers say higher vaccination uptake is needed to protect future gains

THE HPV vaccine for cervical cancer has reduced the risk of dying from the disease before the age of 30 in England to almost zero, the first study of its kind showed on Thursday (18).

Keep ReadingShow less